OKEDI

This brand name is authorized in Austria, Croatia, Estonia, France, Ireland, Italy, Lithuania, Poland, Romania, Spain, UK.

Active ingredients

The drug OKEDI contains one active pharmaceutical ingredient (API):

1	Risperidone UNII L6UH7ZF8HC - RISPERIDONE
	Risperidone is a selective monoaminergic antagonist with unique properties. Although risperidone is a potent D2 antagonist, which is considered to improve the positive symptoms of schizophrenia, it causes less depression of motor activity and induction of catalepsy than classical antipsychotics.
	Read more about Risperidone

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
OKEDI Powder and solvent for suspension for injection	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N05AX08	Risperidone	N Nervous system → N05 Psycholeptics → N05A Antipsychotics → N05AX Other antipsychotics
Discover more medicines within N05AX08

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1875775, 1875786
FR	Base de données publique des médicaments	62548690, 66633241
IT	Agenzia del Farmaco	049966017, 049966029
LT	Valstybinė vaistų kontrolės tarnyba	1094268, 1094269
PL	Rejestru Produktów Leczniczych	100465940, 100467558
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W68774001, W68775001